Meeting with Congress

According to an article published in CenterWatch Weekly (22 Sept. 2014), by Ronald Rosenberg, entitled  “Bipartisan 21st Century Cures Initiative Prepares to Draft Legislation to Accelerate Biomedical R&D, Lower Cost,“ a bipartisan initiative by two U.S. Representatives is about to be drafted into proposed legislation designed to promote novel ways to encourage and accelerate biopharmaceutical innovation. The program, entitled “21st Century Cures: A Call to Action“ is an initiative that seeks broad industry, government, academic and patient advocacy support and input. Rep. Diana DeGette (D-Colo.) and Rep. Fred Upton (R-Mich.). chair of the House Energy and Commerce Committee, are holding Congressional hearings and a series of regional roundtables with industry, patient advocacy and government leaders.

 

Rep. DeGette presented at the Disruptive Innovations to Advance Clinical Trials conference in Boston, sponsored by The Conference Forum, run by our good friend and colleague Valerie Bowling. Dr. Mitchel, President of Target Health, was fortunate to be invited to a breakfast with Rep. DeGette together with representatives from Pfizer, Eli Lilly, Novartis, Roche/Genentech and a patient advocate from the Parkinson’s Disease Foundation. A lot of ideas were shared on how to assure the leadership of the US in basic biomedical research and how to accelerate novel drugs, biologics and devices to the market.

 

20140929-7

Here we are hard at work!!!

 

20140929-8

Back Row (L-R): J. Kim (Eli Lilly); J. Mitchel (Target Health); J. Kasher (Eli Lilly); J. Van Dam (Novartis); C. Lipset (Pfizer)
Front Row (l-R); K. Stem (Genentech); Rep. D. DeGette (Colorado.); V. Bowling (TCF); L. Morgan (Parkinson’s Disease Foundation)

 

ON TARGET is the newsletter of Target Health Inc., a NYC-based, full-service, contract research organization (eCRO), providing strategic planning, regulatory affairs, clinical research, data management, biostatistics, medical writing and software services to the pharmaceutical and device industries, including the paperless clinical trial.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 104). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel or Ms. Joyce Hays. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Comments

Leave a Reply

You must be logged in to post a comment.